Clinical Significance of Asthma Clusters by Longitudinal Analysis in Korean Asthma Cohort

Park, So Young; Baek, Seunghee; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, ByoungWhui; Moon, Hee-Bom; Kim, Tae-Bum
December 2013
PLoS ONE;Dec2013, Vol. 8 Issue 12, p1
Academic Journal
Background: We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma. Methods and Results: A longitudinal analysis of each cluster in a Korean adult asthma cohort was performed to investigate the clinical significance of asthma clusters over 12 months. Cluster A showed relatively high asthma control test (ACT) scores but relatively low FEV1 scores, despite a high percentage of systemic corticosteroid use. Cluster B had the lowest mean FEV1, ACT, and the quality of life questionnaire for adult Korean asthmatics (QLQAKA) scores throughout the year, even though the percentage of systemic corticosteroid use was the highest among the four clusters. Cluster C was ranked second in terms of FEV1, with the second lowest percentage of systemic corticosteroid use, and showed a marked improvement in subjective symptoms over time. Cluster D consistently showed the highest FEV1, the lowest systemic corticosteroid use, and had high ACT and QLQAKA scores. Conclusion: Our asthma clusters had clinical significance with consistency among clusters over 12 months. These distinctive phenotypes may be useful in classifying asthma in real practice.


Related Articles

  • Measures of asthma control and quality of life: longitudinal data provide practical insights into their relative usefulness in different research contexts. King, Madeleine T.; Kenny, Patricia M.; Marks, Guy B. // Quality of Life Research;Apr2009, Vol. 18 Issue 3, p301 

    To further our understanding of the relationships between asthma control and health-related quality of life (HRQOL) and provide insights into the relative usefulness of various measures in different research contexts. We present a conceptual model and test it with longitudinal survey data....

  • Review: Adding antileukotrienes to inhaled corticosteroids reduces exacerbations in symptomatic chronic asthma. Rees, P. John // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p99 

    Comments on a study which investigated the addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Results; Treatment which reduces the rate of exacerbations that require systemic corticosteroids; Effects of inhaled corticosteroids on asthma.

  • High-dose corticosteroids in severe acute asthma. Britton, M.G.; Collins, J.V.; Brown, D.; Fairhurst, N.P.A.; Lambert, R.G. // British Medical Journal;7/10/1976, Vol. 2 Issue 6027, p73 

    Examines the effectiveness of corticosteroid treatment in patients with severe exacerbations of asthma unresponsive to bronchodilators. Assessment of the rates of recovery; Measurement of the peak expiratory flow rate; Use of methylprednisolone in preparing large doses of corticosteroid.

  • Adverse Effects of Inhaled Corticosteroid Therapy. Apgar, Babrbara // American Family Physician;10/1/1999, Vol. 60 Issue 5, p1508 

    Deals with a study that assessed the efficacy of inhaled corticosteroid therapy in patients with asthma along with associated systemic adverse effects. Evaluations of adrenal suppression; Effects of therapy on growth and bone metabolism; Adverse effects on the eyes and skin; Conclusions;...

  • Inhaled vs. Systemic Corticosteroids in Asthma. Miller, Karl E. // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1107 

    Presents a study that hypothesized that the use of high-dosage, inhaled corticosteroids in hospitalized asthma patients could be as well tolerated and effective as oral corticosteroids. Use of systemic corticosteroids in the treatment of hospitalized asthma patients; Advantages of using inhaled...

  • Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma.  // Drugs & Therapy Perspectives;Nov2009, Vol. 25 Issue 11, p1 

    The corticosteroid budesonide and the long-acting β2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI). The combination pMDI improves lung function, asthma control, asthma symptoms and asthma-related quality of life outcomes in patients...

  • Asthma deaths in Cardiff 1963-74: 53 deaths in hospital. MacDonald, J.B.; MacDonald, E.T.; Seaton, A.; Williams, D.A. // British Medical Journal;9/25/1976, Vol. 2 Issue 6038, p721 

    Investigates the factors associated with death from bronchial asthma in Cardiff, Wales. Evaluation of hospital cases; Persistence of fatal attacks prior to admission of patients in hospitals; Underestimation of the severity of the attack by doctors and patients; Underuse of corticosteroid...

  • Is daily inhaled steroid use necessary in the treatment of mild persistent asthma? Stanbrook, Matthew B. // CMAJ: Canadian Medical Association Journal;5/24/2005, Vol. 172 Issue 11, p1439 

    Comments on the study "Daily Versus As-Needed Corticosteroids for Mild Persistent Asthma," by H. A. Boushey, C. A. Sorkness, T. S. King, S. D. Sullivan, J. V. Fahny, S. C. Lazarus, et al. Background on the study; Reasons for the reluctance of asthma patients to adhere to inhaled steroid...

  • Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Dompeling, Edward; van Schayck, Constant P.; van Grunsven, Petrus M.; van Herwaarden, Cees L. A.; Akkermans, Reinier; Molema, Johan; Folgering, Hans; van Weel, Chris; Dompeling, E; van Schayck, C P; van Grunsven, P M; van Herwaarden, C L; Akkermans, R; Molema, J; Folgering, H; van Weel, C // Annals of Internal Medicine;5/15/93, Vol. 118 Issue 10, p770 

    Objective: To determine if deterioration in patients with asthma or chronic obstructive pulmonary disease (COPD) during bronchodilator therapy could be slowed by additional treatment with an inhaled corticosteroid.Design: A 4-year prospective study.Setting:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics